Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 452

1.

Neurofibromin Is an Estrogen Receptor-α Transcriptional Co-repressor in Breast Cancer.

Zheng ZY, Anurag M, Lei JT, Cao J, Singh P, Peng J, Kennedy H, Nguyen NC, Chen Y, Lavere P, Li J, Du XH, Cakar B, Song W, Kim BJ, Shi J, Seker S, Chan DW, Zhao GQ, Chen X, Banks KC, Lanman RB, Shafaee MN, Zhang XH, Vasaikar S, Zhang B, Hilsenbeck SG, Li W, Foulds CE, Ellis MJ, Chang EC.

Cancer Cell. 2020 Mar 16;37(3):387-402.e7. doi: 10.1016/j.ccell.2020.02.003. Epub 2020 Mar 5.

PMID:
32142667
2.

Correction to: Proteomic analysis of degradation ubiquitin signaling by ubiquitin occupancy changes responding to 26S proteasome inhibition.

Hristova V, Sun S, Zhang H, Chan DW.

Clin Proteomics. 2020 Feb 21;17:6. doi: 10.1186/s12014-020-09271-0. eCollection 2020.

3.

Proteomic analysis of degradation ubiquitin signaling by ubiquitin occupancy changes responding to 26S proteasome inhibition.

Hristova V, Sun S, Zhang H, Chan DW.

Clin Proteomics. 2020 Jan 25;17:2. doi: 10.1186/s12014-020-9265-x. eCollection 2020. Erratum in: Clin Proteomics. 2020 Feb 21;17:6.

4.

Microscaled proteogenomic methods for precision oncology.

Satpathy S, Jaehnig EJ, Krug K, Kim BJ, Saltzman AB, Chan DW, Holloway KR, Anurag M, Huang C, Singh P, Gao A, Namai N, Dou Y, Wen B, Vasaikar SV, Mutch D, Watson MA, Ma C, Ademuyiwa FO, Rimawi MF, Schiff R, Hoog J, Jacobs S, Malovannaya A, Hyslop T, Clauser KR, Mani DR, Perou CM, Miles G, Zhang B, Gillette MA, Carr SA, Ellis MJ.

Nat Commun. 2020 Jan 27;11(1):532. doi: 10.1038/s41467-020-14381-2.

5.

Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma.

Clark DJ, Dhanasekaran SM, Petralia F, Pan J, Song X, Hu Y, da Veiga Leprevost F, Reva B, Lih TM, Chang HY, Ma W, Huang C, Ricketts CJ, Chen L, Krek A, Li Y, Rykunov D, Li QK, Chen LS, Ozbek U, Vasaikar S, Wu Y, Yoo S, Chowdhury S, Wyczalkowski MA, Ji J, Schnaubelt M, Kong A, Sethuraman S, Avtonomov DM, Ao M, Colaprico A, Cao S, Cho KC, Kalayci S, Ma S, Liu W, Ruggles K, Calinawan A, Gümüş ZH, Geiszler D, Kawaler E, Teo GC, Wen B, Zhang Y, Keegan S, Li K, Chen F, Edwards N, Pierorazio PM, Chen XS, Pavlovich CP, Hakimi AA, Brominski G, Hsieh JJ, Antczak A, Omelchenko T, Lubinski J, Wiznerowicz M, Linehan WM, Kinsinger CR, Thiagarajan M, Boja ES, Mesri M, Hiltke T, Robles AI, Rodriguez H, Qian J, Fenyö D, Zhang B, Ding L, Schadt E, Chinnaiyan AM, Zhang Z, Omenn GS, Cieslik M, Chan DW, Nesvizhskii AI, Wang P, Zhang H; Clinical Proteomic Tumor Analysis Consortium.

Cell. 2020 Jan 9;180(1):207. doi: 10.1016/j.cell.2019.12.026. No abstract available.

6.

An Integrated Workflow for Global, Glyco-, and Phospho-proteomic Analysis of Tumor Tissues.

Zhou Y, Lih TM, Yang G, Chen SY, Chen L, Chan DW, Zhang H, Li QK.

Anal Chem. 2020 Jan 21;92(2):1842-1849. doi: 10.1021/acs.analchem.9b03753. Epub 2020 Jan 3.

PMID:
31859488
7.

Transcriptomic, epigenetic, and functional analyses implicate neutrophil diversity in the pathogenesis of systemic lupus erythematosus.

Mistry P, Nakabo S, O'Neil L, Goel RR, Jiang K, Carmona-Rivera C, Gupta S, Chan DW, Carlucci PM, Wang X, Naz F, Manna Z, Dey A, Mehta NN, Hasni S, Dell'Orso S, Gutierrez-Cruz G, Sun HW, Kaplan MJ.

Proc Natl Acad Sci U S A. 2019 Dec 10;116(50):25222-25228. doi: 10.1073/pnas.1908576116. Epub 2019 Nov 21.

PMID:
31754025
8.

Right middle cerebral artery infarct after minor head trauma in an infant: Case report and literature review.

Khalid MT, Chan DWS, Tan EEK, Seow WT, Ng LP, Low DCY, Low SYY.

Int J Pediatr Adolesc Med. 2019 Sep;6(3):121-124. doi: 10.1016/j.ijpam.2019.05.005. Epub 2019 May 28.

9.

Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma.

Clark DJ, Dhanasekaran SM, Petralia F, Pan J, Song X, Hu Y, da Veiga Leprevost F, Reva B, Lih TM, Chang HY, Ma W, Huang C, Ricketts CJ, Chen L, Krek A, Li Y, Rykunov D, Li QK, Chen LS, Ozbek U, Vasaikar S, Wu Y, Yoo S, Chowdhury S, Wyczalkowski MA, Ji J, Schnaubelt M, Kong A, Sethuraman S, Avtonomov DM, Ao M, Colaprico A, Cao S, Cho KC, Kalayci S, Ma S, Liu W, Ruggles K, Calinawan A, Gümüş ZH, Geiszler D, Kawaler E, Teo GC, Wen B, Zhang Y, Keegan S, Li K, Chen F, Edwards N, Pierorazio PM, Chen XS, Pavlovich CP, Hakimi AA, Brominski G, Hsieh JJ, Antczak A, Omelchenko T, Lubinski J, Wiznerowicz M, Linehan WM, Kinsinger CR, Thiagarajan M, Boja ES, Mesri M, Hiltke T, Robles AI, Rodriguez H, Qian J, Fenyö D, Zhang B, Ding L, Schadt E, Chinnaiyan AM, Zhang Z, Omenn GS, Cieslik M, Chan DW, Nesvizhskii AI, Wang P, Zhang H; Clinical Proteomic Tumor Analysis Consortium.

Cell. 2019 Oct 31;179(4):964-983.e31. doi: 10.1016/j.cell.2019.10.007. Erratum in: Cell. 2020 Jan 9;180(1):207.

10.

Aberrant upregulation of PDK1 in ovarian cancer cells impairs CD8+ T cell function and survival through elevation of PD-L1.

Wang JJ, Siu MK, Jiang YX, Leung TH, Chan DW, Cheng RR, Cheung AN, Ngan HY, Chan KK.

Oncoimmunology. 2019 Sep 5;8(11):e1659092. doi: 10.1080/2162402X.2019.1659092. eCollection 2019.

PMID:
31646108
11.

p53 Promotes chemoresponsiveness by regulating hexokinase II gene transcription and metabolic reprogramming in epithelial ovarian cancer.

Han CY, Patten DA, Lee SG, Parks RJ, Chan DW, Harper ME, Tsang BK.

Mol Carcinog. 2019 Nov;58(11):2161-2174. doi: 10.1002/mc.23106. Epub 2019 Sep 4.

PMID:
31486135
12.

Targeting of lipid metabolism with a metabolic inhibitor cocktail eradicates peritoneal metastases in ovarian cancer cells.

Chen RR, Yung MMH, Xuan Y, Zhan S, Leung LL, Liang RR, Leung THY, Yang H, Xu D, Sharma R, Chan KKL, Ngu SF, Ngan HYS, Chan DW.

Commun Biol. 2019 Jul 31;2:281. doi: 10.1038/s42003-019-0508-1. eCollection 2019.

13.

Hypertensive urgency in nephrogenic diabetes insipidus with concomitant Hinman syndrome.

Tan YG, Chan DWK, Yap FKP, Yap TL.

BMJ Case Rep. 2019 Jul 27;12(7). pii: e229095. doi: 10.1136/bcr-2018-229095.

PMID:
31352377
14.

ERK Regulates HIF1α-Mediated Platinum Resistance by Directly Targeting PHD2 in Ovarian Cancer.

Li Z, Zhou W, Zhang Y, Sun W, Yung MMH, Sun J, Li J, Chen CW, Li Z, Meng Y, Chai J, Zhou Y, Liu SS, Cheung ANY, Ngan HYS, Chan DW, Zheng W, Zhu W.

Clin Cancer Res. 2019 Oct 1;25(19):5947-5960. doi: 10.1158/1078-0432.CCR-18-4145. Epub 2019 Jul 8.

PMID:
31285371
15.

The interaction of subglottic drainage, cuff pressure, and oral care on endotracheal tube fluid leakage: A benchtop study.

Chair SY, Chan DWK, Cao X.

Aust Crit Care. 2019 Jun 24. pii: S1036-7314(18)30163-2. doi: 10.1016/j.aucc.2019.05.002. [Epub ahead of print]

PMID:
31248697
16.

CD71+ Population Enriched by HPV-E6 Protein Promotes Cancer Aggressiveness and Radioresistance in Cervical Cancer Cells.

Leung TH, Tang HW, Siu MK, Chan DW, Chan KK, Cheung AN, Ngan HY.

Mol Cancer Res. 2019 Sep;17(9):1867-1880. doi: 10.1158/1541-7786.MCR-19-0068. Epub 2019 Jun 24.

PMID:
31235657
17.

Development of a glycoproteomic strategy to detect more aggressive prostate cancer using lectin-immunoassays for serum fucosylated PSA.

Wang C, Höti N, Lih TM, Sokoll LJ, Zhang R, Zhang Z, Zhang H, Chan DW.

Clin Proteomics. 2019 Apr 6;16:13. doi: 10.1186/s12014-019-9234-4. eCollection 2019.

18.

Novel Nuclear Partnering Role of EPS8 With FOXM1 in Regulating Cell Proliferation.

Ngan AWL, Grace Tsui M, So DHF, Leung WY, Chan DW, Yao KM.

Front Oncol. 2019 Mar 19;9:154. doi: 10.3389/fonc.2019.00154. eCollection 2019.

19.

A multiplex immunoassay of serum biomarkers for the detection of uveal melanoma.

Song J, Merbs SL, Sokoll LJ, Chan DW, Zhang Z.

Clin Proteomics. 2019 Mar 5;16:10. doi: 10.1186/s12014-019-9230-8. eCollection 2019.

20.

Validation of a novel model for the early detection of hepatocellular carcinoma.

Hemken PM, Sokoll LJ, Yang X, Dai J, Elliott D, Gawel SH, Lucht M, Feng Z, Marrero JA, Srivastava S, Chan DW, Davis GJ.

Clin Proteomics. 2019 Jan 16;16:2. doi: 10.1186/s12014-018-9222-0. eCollection 2019.

21.

Cancer biomarker discovery and translation: proteomics and beyond.

Hristova VA, Chan DW.

Expert Rev Proteomics. 2019 Feb;16(2):93-103. doi: 10.1080/14789450.2019.1559062. Epub 2018 Dec 24.

22.

Proteome-wide Tyrosine Phosphorylation Analysis Reveals Dysregulated Signaling Pathways in Ovarian Tumors.

Song G, Chen L, Zhang B, Song Q, Yu Y, Moore C, Wang TL, Shih IM, Zhang H, Chan DW, Zhang Z, Zhu H.

Mol Cell Proteomics. 2019 Mar;18(3):448-460. doi: 10.1074/mcp.RA118.000851. Epub 2018 Dec 6.

23.

DPYSL3 modulates mitosis, migration, and epithelial-to-mesenchymal transition in claudin-low breast cancer.

Matsunuma R, Chan DW, Kim BJ, Singh P, Han A, Saltzman AB, Cheng C, Lei JT, Wang J, Roberto da Silva L, Sahin E, Leng M, Fan C, Perou CM, Malovannaya A, Ellis MJ.

Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):E11978-E11987. doi: 10.1073/pnas.1810598115. Epub 2018 Nov 29.

24.

Young girl with bruising: Finding the X factor.

Chan DW, Lam JC.

J Paediatr Child Health. 2019 Apr;55(4):465-467. doi: 10.1111/jpc.14282. Epub 2018 Nov 13. No abstract available.

PMID:
30421520
25.

Parkinson disease: A systemic review of pain sensitivities and its association with clinical pain and response to dopaminergic stimulation.

Sung S, Vijiaratnam N, Chan DWC, Farrell M, Evans AH.

J Neurol Sci. 2018 Dec 15;395:172-206. doi: 10.1016/j.jns.2018.10.013. Epub 2018 Oct 19.

PMID:
30401469
26.

Identification of Serum Biomarker Panels for the Early Detection of Pancreatic Cancer.

Song J, Sokoll LJ, Pasay JJ, Rubin AL, Li H, Bach DM, Chan DW, Zhang Z.

Cancer Epidemiol Biomarkers Prev. 2019 Jan;28(1):174-182. doi: 10.1158/1055-9965.EPI-18-0483. Epub 2018 Oct 17.

27.

miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer.

Sun J, Cai X, Yung MM, Zhou W, Li J, Zhang Y, Li Z, Liu SS, Cheung ANY, Ngan HYS, Li Y, Dai Z, Kai Y, Tzatsos A, Peng W, Chan DW, Zhu W.

Oncogene. 2019 Jan;38(4):564-580. doi: 10.1038/s41388-018-0459-x. Epub 2018 Aug 30.

PMID:
30166592
28.

gpGrouper: A Peptide Grouping Algorithm for Gene-Centric Inference and Quantitation of Bottom-Up Proteomics Data.

Saltzman AB, Leng M, Bhatt B, Singh P, Chan DW, Dobrolecki L, Chandrasekaran H, Choi JM, Jain A, Jung SY, Lewis MT, Ellis MJ, Malovannaya A.

Mol Cell Proteomics. 2018 Nov;17(11):2270-2283. doi: 10.1074/mcp.TIR118.000850. Epub 2018 Aug 9.

29.

Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast Cancer.

Lei JT, Shao J, Zhang J, Iglesia M, Chan DW, Cao J, Anurag M, Singh P, He X, Kosaka Y, Matsunuma R, Crowder R, Hoog J, Phommaly C, Goncalves R, Ramalho S, Peres RMR, Punturi N, Schmidt C, Bartram A, Jou E, Devarakonda V, Holloway KR, Lai WV, Hampton O, Rogers A, Tobias E, Parikh PA, Davies SR, Li S, Ma CX, Suman VJ, Hunt KK, Watson MA, Hoadley KA, Thompson EA, Chen X, Kavuri SM, Creighton CJ, Maher CA, Perou CM, Haricharan S, Ellis MJ.

Cell Rep. 2018 Aug 7;24(6):1434-1444.e7. doi: 10.1016/j.celrep.2018.07.009.

30.

Challenges and opportunities in the proteomic characterization of clear cell renal cell carcinoma (ccRCC): A critical step towards the personalized care of renal cancers.

Li QK, Pavlovich CP, Zhang H, Kinsinger CR, Chan DW.

Semin Cancer Biol. 2019 Apr;55:8-15. doi: 10.1016/j.semcancer.2018.06.004. Epub 2018 Jul 25. Review.

31.

Reproducible workflow for multiplexed deep-scale proteome and phosphoproteome analysis of tumor tissues by liquid chromatography-mass spectrometry.

Mertins P, Tang LC, Krug K, Clark DJ, Gritsenko MA, Chen L, Clauser KR, Clauss TR, Shah P, Gillette MA, Petyuk VA, Thomas SN, Mani DR, Mundt F, Moore RJ, Hu Y, Zhao R, Schnaubelt M, Keshishian H, Monroe ME, Zhang Z, Udeshi ND, Mani D, Davies SR, Townsend RR, Chan DW, Smith RD, Zhang H, Liu T, Carr SA.

Nat Protoc. 2018 Jul;13(7):1632-1661. doi: 10.1038/s41596-018-0006-9.

32.

Changes over time in hip fracture risk: Greater improvements in men compared to women.

Smith R, Perera BK, Chan DWC.

Clin Endocrinol (Oxf). 2018 Sep;89(3):324-329. doi: 10.1111/cen.13763. Epub 2018 Jun 25.

PMID:
29885266
33.

PD-L1 expression is a prognostic factor in subgroups of gastric cancer patients stratified according to their levels of CD8 and FOXP3 immune markers.

Ying L, Yan F, Meng Q, Yu L, Yuan X, Gantier MP, Williams BRG, Chan DW, Shi L, Tu Y, Ni P, Wang X, Chen W, Zang X, Xu D, Hu Y.

Oncoimmunology. 2018 Feb 20;7(6):e1433520. doi: 10.1080/2162402X.2018.1433520. eCollection 2018.

34.

DUOXA1-mediated ROS production promotes cisplatin resistance by activating ATR-Chk1 pathway in ovarian cancer.

Meng Y, Chen CW, Yung MMH, Sun W, Sun J, Li Z, Li J, Li Z, Zhou W, Liu SS, Cheung ANY, Ngan HYS, Braisted JC, Kai Y, Peng W, Tzatsos A, Li Y, Dai Z, Zheng W, Chan DW, Zhu W.

Cancer Lett. 2018 Aug 1;428:104-116. doi: 10.1016/j.canlet.2018.04.029. Epub 2018 Apr 26.

PMID:
29704517
35.

Autocrine activation of JAK2 by IL-11 promotes platinum drug resistance.

Zhou W, Sun W, Yung MMH, Dai S, Cai Y, Chen CW, Meng Y, Lee JB, Braisted JC, Xu Y, Southall NT, Shinn P, Huang X, Song Z, Chen X, Kai Y, Cai X, Li Z, Hao Q, Cheung ANY, Ngan HYS, Liu SS, Barak S, Hao J, Dai Z, Tzatsos A, Peng W, Pei H, Han Z, Chan DW, Zheng W, Zhu W.

Oncogene. 2018 Jul;37(29):3981-3997. doi: 10.1038/s41388-018-0238-8. Epub 2018 Apr 17.

36.

Implementation of safety management systems in Hong Kong construction industry - A safety practitioner's perspective.

Yiu NSN, Sze NN, Chan DWM.

J Safety Res. 2018 Feb;64:1-9. doi: 10.1016/j.jsr.2017.12.011. Epub 2017 Dec 29. Review.

PMID:
29636156
37.

Refractory hyperparathyroidism with a T3 bony lesion-differential diagnoses.

Chan DWC, Moir D, Standish R, Kotowicz MA.

Oxf Med Case Reports. 2018 Mar 20;2018(3):omx109. doi: 10.1093/omcr/omx109. eCollection 2018 Mar.

38.

Combinatorial inhibition of PTPN12-regulated receptors leads to a broadly effective therapeutic strategy in triple-negative breast cancer.

Nair A, Chung HC, Sun T, Tyagi S, Dobrolecki LE, Dominguez-Vidana R, Kurley SJ, Orellana M, Renwick A, Henke DM, Katsonis P, Schmitt E, Chan DW, Li H, Mao S, Petrovic I, Creighton CJ, Gutierrez C, Dubrulle J, Stossi F, Tyner JW, Lichtarge O, Lin CY, Zhang B, Scott KL, Hilsenbeck SG, Sun J, Yu X, Osborne CK, Schiff R, Christensen JG, Shields DJ, Rimawi MF, Ellis MJ, Shaw CA, Lewis MT, Westbrook TF.

Nat Med. 2018 May;24(4):505-511. doi: 10.1038/nm.4507. Epub 2018 Mar 26.

39.

GRO-α and IL-8 enhance ovarian cancer metastatic potential via the CXCR2-mediated TAK1/NFκB signaling cascade.

Yung MM, Tang HW, Cai PC, Leung TH, Ngu SF, Chan KK, Xu D, Yang H, Ngan HY, Chan DW.

Theranostics. 2018 Feb 2;8(5):1270-1285. doi: 10.7150/thno.22536. eCollection 2018.

40.

Pain sensitivity in Parkinson's disease: Systematic review and meta-analysis.

Sung S, Vijiaratnam N, Chan DWC, Farrell M, Evans AH.

Parkinsonism Relat Disord. 2018 Mar;48:17-27. doi: 10.1016/j.parkreldis.2017.12.031. Epub 2017 Dec 29.

PMID:
29398491
41.

Methylation-associated silencing of miR-193a-3p promotes ovarian cancer aggressiveness by targeting GRB7 and MAPK/ERK pathways.

Chen K, Liu MX, Mak CS, Yung MM, Leung TH, Xu D, Ngu SF, Chan KK, Yang H, Ngan HY, Chan DW.

Theranostics. 2018 Jan 1;8(2):423-436. doi: 10.7150/thno.22377. eCollection 2018.

42.

ERBB2 mutation: A promising target in non-squamous cervical cancer.

Xiang L, Jiang W, Ye S, He T, Pei X, Li J, Chan DW, Ngan HYS, Li F, Tao P, Shen X, Zhou X, Wu X, Yang G, Yang H.

Gynecol Oncol. 2018 Feb;148(2):311-316. doi: 10.1016/j.ygyno.2017.12.023. Epub 2017 Dec 24.

PMID:
29279289
43.

A High-Throughput Real-Time Imaging Technique To Quantify NETosis and Distinguish Mechanisms of Cell Death in Human Neutrophils.

Gupta S, Chan DW, Zaal KJ, Kaplan MJ.

J Immunol. 2018 Jan 15;200(2):869-879. doi: 10.4049/jimmunol.1700905. Epub 2017 Dec 1.

44.

Quality Assessments of Long-Term Quantitative Proteomic Analysis of Breast Cancer Xenograft Tissues.

Zhou JY, Chen L, Zhang B, Tian Y, Liu T, Thomas SN, Chen L, Schnaubelt M, Boja E, Hiltke T, Kinsinger CR, Rodriguez H, Davies SR, Li S, Snider JE, Erdmann-Gilmore P, Tabb DL, Townsend RR, Ellis MJ, Rodland KD, Smith RD, Carr SA, Zhang Z, Chan DW, Zhang H.

J Proteome Res. 2017 Dec 1;16(12):4523-4530. doi: 10.1021/acs.jproteome.7b00362. Epub 2017 Nov 16.

45.

A field study of the effectiveness and practicality of a novel hybrid personal cooling vest worn during rest in Hong Kong construction industry.

Chan APC, Zhang Y, Wang F, Wong FFK, Chan DWM.

J Therm Biol. 2017 Dec;70(Pt A):21-27. doi: 10.1016/j.jtherbio.2017.07.012. Epub 2017 Jul 22.

PMID:
29074022
46.

Comparison of heat strain recovery in different anti-heat stress clothing ensembles after work to exhaustion.

Zhao Y, Yi W, Chan APC, Chan DWM.

J Therm Biol. 2017 Oct;69:311-318. doi: 10.1016/j.jtherbio.2017.09.004. Epub 2017 Sep 15.

PMID:
29037399
47.

Understanding immune phenotypes in human gastric disease tissues by multiplexed immunohistochemistry.

Ying L, Yan F, Meng Q, Yuan X, Yu L, Williams BRG, Chan DW, Shi L, Tu Y, Ni P, Wang X, Xu D, Hu Y.

J Transl Med. 2017 Oct 12;15(1):206. doi: 10.1186/s12967-017-1311-8.

48.

Human papillomavirus E6 protein enriches the CD55(+) population in cervical cancer cells, promoting radioresistance and cancer aggressiveness.

Leung TH, Tang HW, Siu MK, Chan DW, Chan KK, Cheung AN, Ngan HY.

J Pathol. 2018 Feb;244(2):151-163. doi: 10.1002/path.4991. Epub 2017 Dec 19.

PMID:
28944962
49.

Multi-laboratory assessment of reproducibility, qualitative and quantitative performance of SWATH-mass spectrometry.

Collins BC, Hunter CL, Liu Y, Schilling B, Rosenberger G, Bader SL, Chan DW, Gibson BW, Gingras AC, Held JM, Hirayama-Kurogi M, Hou G, Krisp C, Larsen B, Lin L, Liu S, Molloy MP, Moritz RL, Ohtsuki S, Schlapbach R, Selevsek N, Thomas SN, Tzeng SC, Zhang H, Aebersold R.

Nat Commun. 2017 Aug 21;8(1):291. doi: 10.1038/s41467-017-00249-5.

50.

Protein signatures of molecular pathways in non-small cell lung carcinoma (NSCLC): comparison of glycoproteomics and global proteomics.

Yang S, Chen L, Chan DW, Li QK, Zhang H.

Clin Proteomics. 2017 Aug 15;14:31. doi: 10.1186/s12014-017-9166-9. eCollection 2017.

Supplemental Content

Support Center